# EDGAR Filing Document

**Accession Number:** 0001424768
**File Stem:** 0001493152-23-010407
**Filing Date:** 2023-3
**Character Count:** 4890
**Document Hash:** b8ae305e53d8ea1572f2783dee0d7760
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-010407.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001493152-23-010407

**CONFORMED SUBMISSION TYPE**: NT 10-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**EFFECTIVENESS DATE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VYCOR MEDICAL INC
- **CENTRAL INDEX KEY:** 0001424768
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 203369218
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NT 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34932
- **FILM NUMBER:** 23789148

**BUSINESS ADDRESS:**
- **STREET 1:** 951 BROKEN SOUND PARKWAY
- **STREET 2:** SUITE 320
- **CITY:** BOCA RATON,
- **STATE:** FL
- **ZIP:** 33487
- **BUSINESS PHONE:** 562.558.2000

**MAIL ADDRESS:**
- **STREET 1:** 951 BROKEN SOUND PARKWAY
- **STREET 2:** SUITE 320
- **CITY:** BOCA RATON,
- **STATE:** FL
- **ZIP:** 33487

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 12b-25**

Commission File Number <u>000-53754</u>

**NOTIFICATION OF LATE FILING**

(Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR

For Period Ended: December 31, 2022

---

| | | | |
|:---|:---|:---|:---|
| ☐ | Transition Report on Form 10-K | ☐ | Transition Report on Form 10-Q |
| ☐ | Transition Report on Form 20-F | ☐ | Transition Report on Form N-SAR |
| ☐ | Transition Report on Form 11-K |  |  |

---

For Transition Period Ended:  

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:_______________________________________________________________

**PART I**

**REGISTRANT INFORMATION**

Full name of registrant: VYCOR MEDICAL, INC.

Address of principal executive office (Street and number): 951 Broken Sound Pkwy, Suite 320

Boca Raton, FL 33487

**PART II**

**RULE 12-b 25 (b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

☐ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

☐ (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

**PART III**

**NARRATIVE**

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The Registrant is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense due to the complexity of certain of its operations. The Registrant anticipates that it will file its Form 10-K within the grace period provided by Exchange Act Rule 12b-25.

**PART IV**

**OTHER INFORMATION**

(1) Name and telephone number of person to contact in regard to this notification: Adrian Liddell, Chief Financial Officer, Tel. (561) 558-2000.

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

☐ Yes ☒ No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

<u>VYCOR MEDICAL, INC.</u> <br> (Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| VYCOR MEDICAL, INC. | VYCOR MEDICAL, INC. |
| By: | */S/ Adrian Liddell* |
|  | Adrian Liddell |
|  | Chief Financial Officer |

---

Date: March 31, 2023